Cargando...
Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting
Despite relevant medical advancements, metastatic breast cancer remains an uncurable disease. HER2 signaling conditions tumor behavior and treatment strategies of HER2 expressing breast cancer. Cancer treatment guidelines uniformly identify dual blockade with pertuzumab and trastuzumab plus a taxane...
Guardado en:
Publicado en: | Oncotarget |
---|---|
Autores principales: | , , , , , , , , , , , , , , |
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7275781/ https://ncbi.nlm.nih.gov/pubmed/32547706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27603 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|